Skip to content

Menten AI

YC W20 · Active · Menten AI designs peptide and protein therapeutics using quantum…

Competitors

Adjacent

Also from W20 in AI

All of W20

About Menten AI

Menten AI designs protein drugs and enzymes using quantum computing and machine learning. Their technology leapfrogs current computational methods making it possible to design previously intractable proteins. The team created the first protein design algorithm for current and near-term quantum computers and created the world’s first protein designed on a quantum computer. They are now working on 3 new proteins, including a peptide to prevent the spread of viruses like Covid-19. They have 2 paid pilot projects with multinational chemical companies and 4 LOI’s with pharma and biotech companies.

YC batch
W20 · Winter 2020
Status, per YC
Active
Category
AI
Team size
2
Location
San Francisco, CA, USA
Checked
34m ago

YC tags: AI-powered Drug Discovery, Quantum Computing

Menten AI in W20: 228 companies, 29% AI

Menten AI: questions

Which YC batch was Menten AI in?

Menten AI was in Y Combinator's Winter 2020 batch (W20).

Is Menten AI still active?

Y Combinator lists Menten AI as active.

Where is Menten AI based?

Menten AI lists San Francisco, CA, USA as its location on YC's directory.

Sources: each program's public company list, read twice a week. Not affiliated with Y Combinator or any other program. Logos via logo.dev; trademarks belong to their owners.

New startups by email

Mondays: new YC data, AI and devtools companies and status changes, only when something changed.

Double opt-in. Unsubscribe any time.